| N(%) | GCRG213p negative | GCRG213p positive | P value |
---|---|---|---|---|
Gender | Â | Â | Â | Â |
  Male | 144(82.28%) | 31 | 113 | 0.111 |
  Female | 31(17.72%) | 11 | 20 |  |
Age | Â | Â | Â | Â |
  <65 year | 104(59.43%) | 31 | 73 | 0.029 |
  ≥65 year | 71(40.57%) | 11 | 60 |  |
Smoking | Â | Â | Â | Â |
  Yes | 45(27.27%) | 7 | 38 | 0.278 |
  No | 120(72.73%) | 30 | 90 |  |
Drinking | Â | Â | Â | Â |
  Yes | 28(16.97%) | 2 | 26 | 0.060 |
  No | 137(83.03%) | 35 | 102 |  |
Family history of tumor | Â | Â | Â | Â |
  Yes | 14(8.43%) | 2 | 12 | 0.639 |
  No | 152(91.57%) | 36 | 116 |  |
Tumor location | Â | Â | Â | Â |
  Cardiac | 48(27.43%) | 8 | 40 | 0.360 |
  Body | 37(21.14%) | 10 | 27 |  |
  Antrum | 90(51.43%) | 24 | 66 |  |
Tumor size (cm) | Â | Â | Â | Â |
  ≤1 | 11(6.29%) | 3 | 8 | 0.506 |
  1-3 | 42(24.00%) | 13 | 29 |  |
  >3 | 122(69.71%) | 26 | 96 |  |
Depth of invasion | Â | Â | Â | Â |
  T1 | 46(26.28%) | 12 | 34 | 0.635 |
  T2 | 21(12.00%) | 7 | 14 |  |
  T3 | 33(18.86%) | 6 | 27 |  |
  T4 | 75(42.86%) | 17 | 58 |  |
Lymph node involvement | Â | Â | Â | Â |
  Yes | 75(42.86%) | 16 | 59 | 0.592 |
  No | 100(57.14%) | 26 | 74 |  |
Grade of tumor differentiation | Â | Â | Â | Â |
  Well | 10(5.71%) | 0 | 10 | 0.001 |
  Moderate | 40(22.86%) | 4 | 36 |  |
  Poor | 103(58.86%) | 27 | 76 |  |
  Signet ring cell | 22(12.57%) | 11 | 11 |  |
Tumour stage (TNM) | Â | Â | Â | Â |
  0 | 21(12.00%) | 3 | 18 | 0.217 |
  Ia | 14(8.00%) | 6 | 8 |  |
  Ib | 41(23.43%) | 10 | 31 |  |
  II | 60(34.29%) | 17 | 43 |  |
  IIIa | 39(22.28%) | 6 | 33 |  |
Lauren’s classification |  |  |  |  |
  Intestinal type | 153(87.43%) | 31 | 122 | 0.015 |
  Diffuse type | 22(12.57%) | 11 | 11 |  |
Resection margin | Â | Â | Â | Â |
  Presence | 6(3.43%) | 0 | 6 | 0.361 |
  Absence | 169(96.57%) | 42 | 127 |  |
Microvascular invasion | Â | Â | Â | Â |
  Presence | 20(11.43%) | 5 | 15 | 0.911 |
  Absence | 155(88.57%) | 37 | 118 |  |
Status | Â | Â | Â | Â |
  alive | 121(71.18%) | 30 | 91 | 0.483 |
  dead | 49(28.82%) | 9 | 40 |  |
5Â year survival | Â | Â | Â | Â |
  <5 yr | 47(43.93%) | 12 | 48 | 0.871 |
  > = 5 yr | 60(50.07%) | 10 | 37 |  |